GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Core One Labs Inc (OTCPK:CLABF) » Definitions » EV-to-EBIT

Core One Labs (Core One Labs) EV-to-EBIT : -5.27 (As of May. 04, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Core One Labs EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Core One Labs's Enterprise Value is $7.96 Mil. Core One Labs's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.51 Mil. Therefore, Core One Labs's EV-to-EBIT for today is -5.27.

The historical rank and industry rank for Core One Labs's EV-to-EBIT or its related term are showing as below:

CLABF' s EV-to-EBIT Range Over the Past 10 Years
Min: -15.77   Med: -2.09   Max: -0.31
Current: -5.27

During the past 11 years, the highest EV-to-EBIT of Core One Labs was -0.31. The lowest was -15.77. And the median was -2.09.

CLABF's EV-to-EBIT is ranked worse than
100% of 434 companies
in the Biotechnology industry
Industry Median: 8.915 vs CLABF: -5.27

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Core One Labs's Enterprise Value for the quarter that ended in Dec. 2023 was $11.23 Mil. Core One Labs's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.51 Mil. Core One Labs's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -13.44%.


Core One Labs EV-to-EBIT Historical Data

The historical data trend for Core One Labs's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Core One Labs EV-to-EBIT Chart

Core One Labs Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.81 -2.53 -1.23 -1.77 -0.38

Core One Labs Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.88 -1.44 -1.73 -4.63 -6.70

Competitive Comparison of Core One Labs's EV-to-EBIT

For the Biotechnology subindustry, Core One Labs's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Core One Labs's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Core One Labs's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Core One Labs's EV-to-EBIT falls into.



Core One Labs EV-to-EBIT Calculation

Core One Labs's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=7.962/-1.51
=-5.27

Core One Labs's current Enterprise Value is $7.96 Mil.
Core One Labs's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.51 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Core One Labs  (OTCPK:CLABF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Core One Labs's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-1.51/11.23351032
=-13.44 %

Core One Labs's Enterprise Value for the quarter that ended in Dec. 2023 was $11.23 Mil.
Core One Labs's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.51 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Core One Labs EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Core One Labs's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Core One Labs (Core One Labs) Business Description

Traded in Other Exchanges
Address
1199 West Hastings Street, Suite 800, Vancouver, BC, CAN, V6E 3T5
Core One Labs Inc is a psychedelic research and development life sciences enterprise focused on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy. The company intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. The Company operates a virtual clinic that assesses patients for the appropriateness of treatment plans for the use of medical cannabis to treat their symptoms. The Company partners with physicians and Health Canada's licensed producers for the provision of treatments, fulfillment of prescriptions, and sale of related products.

Core One Labs (Core One Labs) Headlines

From GuruFocus

Core One in Talks with Multiple Companies to Supply Psilocybin

By ACCESSWIRE ACCESSWIRE 05-06-2023